Malignant lymphoma of soft tissue in an HIV-1+ patient. A rare site for primary malignant lymphoma with implications for treatment. Military Medical Consortium for the Advancement of Retroviral Research.

Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.

Am J Dermatopathol. 1995 Aug;17(4):403-6. Unique Identifier : AIDSLINE MED/96166830
Smith KJ; Skelton HG; Ruiz N; Laskin W; Wagner KF; Department of Dermatopathology, Armed Forces Institute of; Pathology, Washington, DC 20306, USA.

Abstract: Soft tissue lymphomas are rare; however, the only large reported series has indicated that soft tissue lymphomas may have a better prognosis than similar-grade tumors found at other sites, and even high-grade lesions may respond to local therapies. We present a human immunodeficiency virus type 1 (HIV-1)-positive, Walter Reed stage VI black male with a documented high-grade soft tissue non-Hodgkin's lymphoma with no other evidence of tumor on complete systemic evaluation. Although extranodal lymphomas are common in HIV-1 disease, we are aware of no other reports of a soft tissue lymphoma in an HIV-1-positive patient. A significant percentage of soft tissue lymphomas in the general population, even when they are high grade, responds to local therapies including surgical excision and radiation. Thus, confirmation of this diagnosis in HIV-1 disease may be important, because these patients frequently develop fatal opportunistic infections and tolerate chemotherapy poorly, especially in late stages of disease.

Keywords: Adult AIDS-Related Opportunistic Infections/ETIOLOGY Case Report Combined Modality Therapy Human *HIV Seropositivity *HIV-1 Lymphoma, AIDS-Related/*PATHOLOGY/SURGERY Lymphoma, High-Grade/*PATHOLOGY/SURGERY Lymphoma, Lymphoblastic/PATHOLOGY/SURGERY Lymphoma, Small-Cell/PATHOLOGY/SURGERY Male Soft Tissue Neoplasms/*PATHOLOGY/SURGERY Thoracic Neoplasms/*PATHOLOGY/SURGERY JOURNAL ARTICLE
960730
M9670479

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .